カテゴリー： LP Information, 世界, 医療/バイオ

世界の肥満治療装置市場予測 2023年-2029年

◆英語タイトル：Global Obesity Treatment Devices Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23JU4010）◆商品コード：LP23JU4010
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年5月
◆ページ数：114
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医療装置＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の肥満治療装置市場」は、過去の販売実績から2022年の世界の肥満治療装置の総販売量を検討し、2023年から2029年の予測される肥満治療装置の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の肥満治療装置の市場規模を掲載し、XXX百万米ドル規模の世界の肥満治療装置市場の詳細な分析を提供します。本インサイトレポートは、世界の肥満治療装置業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の肥満治療装置市場における各社の独自のポジションをより深く理解するために、肥満治療装置製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の肥満治療装置市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。肥満治療装置の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。肥満治療装置の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。肥満治療装置のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

肥満治療装置の世界主要メーカーとしては、Allergan, Inc.、 Apollo Endosurgery, Inc.、 Aspire Medical, Inc. (Aspire Bariatrics)、 Boston Scientific Corp.、 Cousin Biotech、 CR Bard, Inc.、 EnteroMedics, Inc.、 GI Dynamics, Inc.、 GI Windows, Inc.、 Johnson & Johnson、 Leptos Biomedical、 Mediflex Surgical Products、 Medtronic, Inc.、 ReShape Medical, Inc.、 Satiety, Inc.、 Spatz FGIA, Inc.、 TransEnterix, Inc.などを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の肥満治療装置市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では肥満治療装置市場をセグメンテーションし、種類別 (胃バンディング装置、胃バルーン装置、胃電気刺激装置、胃排出/胃吸引装置、その他)、用途別 (病院、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：胃バンディング装置、胃バルーン装置、胃電気刺激装置、胃排出/胃吸引装置、その他

・用途別区分：病院、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の肥満治療装置市場の10年間の市場状況・展望は？
・世界および地域別に見た肥満治療装置市場成長の要因は何か？
・肥満治療装置の市場機会はエンドマーケットの規模によってどのように変化するのか？
・肥満治療装置のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：肥満治療装置の年間販売量2018-2029、地域別現状・将来分析
・肥満治療装置の種類別セグメント：胃バンディング装置、胃バルーン装置、胃電気刺激装置、胃排出/胃吸引装置、その他
・肥満治療装置の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・肥満治療装置の用途別セグメント：病院、診療所、その他
・肥満治療装置の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の肥満治療装置市場
・企業別のグローバル肥満治療装置市場データ：2018-2023年の年間販売量、市場シェア
・企業別の肥満治療装置の年間売上：2018-2023年の売上、市場シェア
・企業別の肥満治療装置販売価格
・主要企業の肥満治療装置生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

肥満治療装置の地域別レビュー
・地域別の肥満治療装置市場規模2018-2023：年間販売量、売上
・主要国別の肥満治療装置市場規模2018-2023：年間販売量、売上
・南北アメリカの肥満治療装置販売の成長
・アジア太平洋の肥満治療装置販売の成長
・ヨーロッパの肥満治療装置販売の成長
・中東・アフリカの肥満治療装置販売の成長

南北アメリカ市場
・南北アメリカの国別の肥満治療装置販売量、売上（2018-2023）
・南北アメリカの肥満治療装置の種類別販売量
・南北アメリカの肥満治療装置の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の肥満治療装置販売量、売上（2018-2023）
・アジア太平洋の肥満治療装置の種類別販売量
・アジア太平洋の肥満治療装置の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の肥満治療装置販売量、売上（2018-2023）
・ヨーロッパの肥満治療装置の種類別販売量
・ヨーロッパの肥満治療装置の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の肥満治療装置販売量、売上（2018-2023）
・中東・アフリカの肥満治療装置の種類別販売量
・中東・アフリカの肥満治療装置の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・肥満治療装置の製造コスト構造分析
・肥満治療装置の製造プロセス分析
・肥満治療装置の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・肥満治療装置の主要なグローバル販売業者
・肥満治療装置の主要なグローバル顧客

地域別の肥満治療装置市場予測レビュー
・地域別の肥満治療装置市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・肥満治療装置の種類別市場規模予測
・肥満治療装置の用途別市場規模予測

主要企業分析
Allergan, Inc.、 Apollo Endosurgery, Inc.、 Aspire Medical, Inc. (Aspire Bariatrics)、 Boston Scientific Corp.、 Cousin Biotech、 CR Bard, Inc.、 EnteroMedics, Inc.、 GI Dynamics, Inc.、 GI Windows, Inc.、 Johnson & Johnson、 Leptos Biomedical、 Mediflex Surgical Products、 Medtronic, Inc.、 ReShape Medical, Inc.、 Satiety, Inc.、 Spatz FGIA, Inc.、 TransEnterix, Inc.
・企業情報
・肥満治療装置製品
・肥満治療装置販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

LPI (LP Information)’ newest research report, the “Obesity Treatment Devices Industry Forecast” looks at past sales and reviews total world Obesity Treatment Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Obesity Treatment Devices sales for 2023 through 2029. With Obesity Treatment Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Obesity Treatment Devices industry.
This Insight Report provides a comprehensive analysis of the global Obesity Treatment Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Obesity Treatment Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Obesity Treatment Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Obesity Treatment Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Obesity Treatment Devices.
The global Obesity Treatment Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Obesity Treatment Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Obesity Treatment Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Obesity Treatment Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Obesity Treatment Devices players cover Allergan, Inc., Apollo Endosurgery, Inc., Aspire Medical, Inc. (Aspire Bariatrics), Boston Scientific Corp., Cousin Biotech, CR Bard, Inc., EnteroMedics, Inc., GI Dynamics, Inc. and GI Windows, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Obesity Treatment Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Gastric Banding Systems
Gastric Balloon Systems
Gastric Electrical Stimulation Systems
Gastric Emptying Systems or Gastric Aspiration Systems
Other
Segmentation by application
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Allergan, Inc.
Apollo Endosurgery, Inc.
Aspire Medical, Inc. (Aspire Bariatrics)
Boston Scientific Corp.
Cousin Biotech
CR Bard, Inc.
EnteroMedics, Inc.
GI Dynamics, Inc.
GI Windows, Inc.
Johnson & Johnson
Leptos Biomedical
Mediflex Surgical Products
Medtronic, Inc.
ReShape Medical, Inc.
Satiety, Inc.
Spatz FGIA, Inc.
TransEnterix, Inc.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Obesity Treatment Devices market?
What factors are driving Obesity Treatment Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Obesity Treatment Devices market opportunities vary by end market size?
How does Obesity Treatment Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Obesity Treatment Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Obesity Treatment Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Obesity Treatment Devices by Country/Region, 2018, 2022 & 2029
2.2 Obesity Treatment Devices Segment by Type
2.2.1 Gastric Banding Systems
2.2.2 Gastric Balloon Systems
2.2.3 Gastric Electrical Stimulation Systems
2.2.4 Gastric Emptying Systems or Gastric Aspiration Systems
2.2.5 Other
2.3 Obesity Treatment Devices Sales by Type
2.3.1 Global Obesity Treatment Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Obesity Treatment Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Obesity Treatment Devices Sale Price by Type (2018-2023)
2.4 Obesity Treatment Devices Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Obesity Treatment Devices Sales by Application
2.5.1 Global Obesity Treatment Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Obesity Treatment Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Obesity Treatment Devices Sale Price by Application (2018-2023)
3 Global Obesity Treatment Devices by Company
3.1 Global Obesity Treatment Devices Breakdown Data by Company
3.1.1 Global Obesity Treatment Devices Annual Sales by Company (2018-2023)
3.1.2 Global Obesity Treatment Devices Sales Market Share by Company (2018-2023)
3.2 Global Obesity Treatment Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Obesity Treatment Devices Revenue by Company (2018-2023)
3.2.2 Global Obesity Treatment Devices Revenue Market Share by Company (2018-2023)
3.3 Global Obesity Treatment Devices Sale Price by Company
3.4 Key Manufacturers Obesity Treatment Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Obesity Treatment Devices Product Location Distribution
3.4.2 Players Obesity Treatment Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Obesity Treatment Devices by Geographic Region
4.1 World Historic Obesity Treatment Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Obesity Treatment Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Obesity Treatment Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Obesity Treatment Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Obesity Treatment Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Obesity Treatment Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Obesity Treatment Devices Sales Growth
4.4 APAC Obesity Treatment Devices Sales Growth
4.5 Europe Obesity Treatment Devices Sales Growth
4.6 Middle East & Africa Obesity Treatment Devices Sales Growth
5 Americas
5.1 Americas Obesity Treatment Devices Sales by Country
5.1.1 Americas Obesity Treatment Devices Sales by Country (2018-2023)
5.1.2 Americas Obesity Treatment Devices Revenue by Country (2018-2023)
5.2 Americas Obesity Treatment Devices Sales by Type
5.3 Americas Obesity Treatment Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Obesity Treatment Devices Sales by Region
6.1.1 APAC Obesity Treatment Devices Sales by Region (2018-2023)
6.1.2 APAC Obesity Treatment Devices Revenue by Region (2018-2023)
6.2 APAC Obesity Treatment Devices Sales by Type
6.3 APAC Obesity Treatment Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Obesity Treatment Devices by Country
7.1.1 Europe Obesity Treatment Devices Sales by Country (2018-2023)
7.1.2 Europe Obesity Treatment Devices Revenue by Country (2018-2023)
7.2 Europe Obesity Treatment Devices Sales by Type
7.3 Europe Obesity Treatment Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Obesity Treatment Devices by Country
8.1.1 Middle East & Africa Obesity Treatment Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Obesity Treatment Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Obesity Treatment Devices Sales by Type
8.3 Middle East & Africa Obesity Treatment Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Obesity Treatment Devices
10.3 Manufacturing Process Analysis of Obesity Treatment Devices
10.4 Industry Chain Structure of Obesity Treatment Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Obesity Treatment Devices Distributors
11.3 Obesity Treatment Devices Customer
12 World Forecast Review for Obesity Treatment Devices by Geographic Region
12.1 Global Obesity Treatment Devices Market Size Forecast by Region
12.1.1 Global Obesity Treatment Devices Forecast by Region (2024-2029)
12.1.2 Global Obesity Treatment Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Obesity Treatment Devices Forecast by Type
12.7 Global Obesity Treatment Devices Forecast by Application
13 Key Players Analysis
13.1 Allergan, Inc.
13.1.1 Allergan, Inc. Company Information
13.1.2 Allergan, Inc. Obesity Treatment Devices Product Portfolios and Specifications
13.1.3 Allergan, Inc. Obesity Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Allergan, Inc. Main Business Overview
13.1.5 Allergan, Inc. Latest Developments
13.2 Apollo Endosurgery, Inc.
13.2.1 Apollo Endosurgery, Inc. Company Information
13.2.2 Apollo Endosurgery, Inc. Obesity Treatment Devices Product Portfolios and Specifications
13.2.3 Apollo Endosurgery, Inc. Obesity Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Apollo Endosurgery, Inc. Main Business Overview
13.2.5 Apollo Endosurgery, Inc. Latest Developments
13.3 Aspire Medical, Inc. (Aspire Bariatrics)
13.3.1 Aspire Medical, Inc. (Aspire Bariatrics) Company Information
13.3.2 Aspire Medical, Inc. (Aspire Bariatrics) Obesity Treatment Devices Product Portfolios and Specifications
13.3.3 Aspire Medical, Inc. (Aspire Bariatrics) Obesity Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Aspire Medical, Inc. (Aspire Bariatrics) Main Business Overview
13.3.5 Aspire Medical, Inc. (Aspire Bariatrics) Latest Developments
13.4 Boston Scientific Corp.
13.4.1 Boston Scientific Corp. Company Information
13.4.2 Boston Scientific Corp. Obesity Treatment Devices Product Portfolios and Specifications
13.4.3 Boston Scientific Corp. Obesity Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Boston Scientific Corp. Main Business Overview
13.4.5 Boston Scientific Corp. Latest Developments
13.5 Cousin Biotech
13.5.1 Cousin Biotech Company Information
13.5.2 Cousin Biotech Obesity Treatment Devices Product Portfolios and Specifications
13.5.3 Cousin Biotech Obesity Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cousin Biotech Main Business Overview
13.5.5 Cousin Biotech Latest Developments
13.6 CR Bard, Inc.
13.6.1 CR Bard, Inc. Company Information
13.6.2 CR Bard, Inc. Obesity Treatment Devices Product Portfolios and Specifications
13.6.3 CR Bard, Inc. Obesity Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 CR Bard, Inc. Main Business Overview
13.6.5 CR Bard, Inc. Latest Developments
13.7 EnteroMedics, Inc.
13.7.1 EnteroMedics, Inc. Company Information
13.7.2 EnteroMedics, Inc. Obesity Treatment Devices Product Portfolios and Specifications
13.7.3 EnteroMedics, Inc. Obesity Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 EnteroMedics, Inc. Main Business Overview
13.7.5 EnteroMedics, Inc. Latest Developments
13.8 GI Dynamics, Inc.
13.8.1 GI Dynamics, Inc. Company Information
13.8.2 GI Dynamics, Inc. Obesity Treatment Devices Product Portfolios and Specifications
13.8.3 GI Dynamics, Inc. Obesity Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 GI Dynamics, Inc. Main Business Overview
13.8.5 GI Dynamics, Inc. Latest Developments
13.9 GI Windows, Inc.
13.9.1 GI Windows, Inc. Company Information
13.9.2 GI Windows, Inc. Obesity Treatment Devices Product Portfolios and Specifications
13.9.3 GI Windows, Inc. Obesity Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 GI Windows, Inc. Main Business Overview
13.9.5 GI Windows, Inc. Latest Developments
13.10 Johnson & Johnson
13.10.1 Johnson & Johnson Company Information
13.10.2 Johnson & Johnson Obesity Treatment Devices Product Portfolios and Specifications
13.10.3 Johnson & Johnson Obesity Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Johnson & Johnson Main Business Overview
13.10.5 Johnson & Johnson Latest Developments
13.11 Leptos Biomedical
13.11.1 Leptos Biomedical Company Information
13.11.2 Leptos Biomedical Obesity Treatment Devices Product Portfolios and Specifications
13.11.3 Leptos Biomedical Obesity Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Leptos Biomedical Main Business Overview
13.11.5 Leptos Biomedical Latest Developments
13.12 Mediflex Surgical Products
13.12.1 Mediflex Surgical Products Company Information
13.12.2 Mediflex Surgical Products Obesity Treatment Devices Product Portfolios and Specifications
13.12.3 Mediflex Surgical Products Obesity Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Mediflex Surgical Products Main Business Overview
13.12.5 Mediflex Surgical Products Latest Developments
13.13 Medtronic, Inc.
13.13.1 Medtronic, Inc. Company Information
13.13.2 Medtronic, Inc. Obesity Treatment Devices Product Portfolios and Specifications
13.13.3 Medtronic, Inc. Obesity Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Medtronic, Inc. Main Business Overview
13.13.5 Medtronic, Inc. Latest Developments
13.14 ReShape Medical, Inc.
13.14.1 ReShape Medical, Inc. Company Information
13.14.2 ReShape Medical, Inc. Obesity Treatment Devices Product Portfolios and Specifications
13.14.3 ReShape Medical, Inc. Obesity Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 ReShape Medical, Inc. Main Business Overview
13.14.5 ReShape Medical, Inc. Latest Developments
13.15 Satiety, Inc.
13.15.1 Satiety, Inc. Company Information
13.15.2 Satiety, Inc. Obesity Treatment Devices Product Portfolios and Specifications
13.15.3 Satiety, Inc. Obesity Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Satiety, Inc. Main Business Overview
13.15.5 Satiety, Inc. Latest Developments
13.16 Spatz FGIA, Inc.
13.16.1 Spatz FGIA, Inc. Company Information
13.16.2 Spatz FGIA, Inc. Obesity Treatment Devices Product Portfolios and Specifications
13.16.3 Spatz FGIA, Inc. Obesity Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Spatz FGIA, Inc. Main Business Overview
13.16.5 Spatz FGIA, Inc. Latest Developments
13.17 TransEnterix, Inc.
13.17.1 TransEnterix, Inc. Company Information
13.17.2 TransEnterix, Inc. Obesity Treatment Devices Product Portfolios and Specifications
13.17.3 TransEnterix, Inc. Obesity Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 TransEnterix, Inc. Main Business Overview
13.17.5 TransEnterix, Inc. Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Obesity Treatment Devices Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Obesity Treatment Devices Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Gastric Banding Systems
Table 4. Major Players of Gastric Balloon Systems
Table 5. Major Players of Gastric Electrical Stimulation Systems
Table 6. Major Players of Gastric Emptying Systems or Gastric Aspiration Systems
Table 7. Major Players of Other
Table 8. Global Obesity Treatment Devices Sales by Type (2018-2023) & (K Units)
Table 9. Global Obesity Treatment Devices Sales Market Share by Type (2018-2023)
Table 10. Global Obesity Treatment Devices Revenue by Type (2018-2023) & ($ million)
Table 11. Global Obesity Treatment Devices Revenue Market Share by Type (2018-2023)
Table 12. Global Obesity Treatment Devices Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Obesity Treatment Devices Sales by Application (2018-2023) & (K Units)
Table 14. Global Obesity Treatment Devices Sales Market Share by Application (2018-2023)
Table 15. Global Obesity Treatment Devices Revenue by Application (2018-2023)
Table 16. Global Obesity Treatment Devices Revenue Market Share by Application (2018-2023)
Table 17. Global Obesity Treatment Devices Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Obesity Treatment Devices Sales by Company (2018-2023) & (K Units)
Table 19. Global Obesity Treatment Devices Sales Market Share by Company (2018-2023)
Table 20. Global Obesity Treatment Devices Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Obesity Treatment Devices Revenue Market Share by Company (2018-2023)
Table 22. Global Obesity Treatment Devices Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Obesity Treatment Devices Producing Area Distribution and Sales Area
Table 24. Players Obesity Treatment Devices Products Offered
Table 25. Obesity Treatment Devices Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Obesity Treatment Devices Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Obesity Treatment Devices Sales Market Share Geographic Region (2018-2023)
Table 30. Global Obesity Treatment Devices Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Obesity Treatment Devices Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Obesity Treatment Devices Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Obesity Treatment Devices Sales Market Share by Country/Region (2018-2023)
Table 34. Global Obesity Treatment Devices Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Obesity Treatment Devices Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Obesity Treatment Devices Sales by Country (2018-2023) & (K Units)
Table 37. Americas Obesity Treatment Devices Sales Market Share by Country (2018-2023)
Table 38. Americas Obesity Treatment Devices Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Obesity Treatment Devices Revenue Market Share by Country (2018-2023)
Table 40. Americas Obesity Treatment Devices Sales by Type (2018-2023) & (K Units)
Table 41. Americas Obesity Treatment Devices Sales by Application (2018-2023) & (K Units)
Table 42. APAC Obesity Treatment Devices Sales by Region (2018-2023) & (K Units)
Table 43. APAC Obesity Treatment Devices Sales Market Share by Region (2018-2023)
Table 44. APAC Obesity Treatment Devices Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Obesity Treatment Devices Revenue Market Share by Region (2018-2023)
Table 46. APAC Obesity Treatment Devices Sales by Type (2018-2023) & (K Units)
Table 47. APAC Obesity Treatment Devices Sales by Application (2018-2023) & (K Units)
Table 48. Europe Obesity Treatment Devices Sales by Country (2018-2023) & (K Units)
Table 49. Europe Obesity Treatment Devices Sales Market Share by Country (2018-2023)
Table 50. Europe Obesity Treatment Devices Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Obesity Treatment Devices Revenue Market Share by Country (2018-2023)
Table 52. Europe Obesity Treatment Devices Sales by Type (2018-2023) & (K Units)
Table 53. Europe Obesity Treatment Devices Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Obesity Treatment Devices Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Obesity Treatment Devices Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Obesity Treatment Devices Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Obesity Treatment Devices Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Obesity Treatment Devices Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Obesity Treatment Devices Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Obesity Treatment Devices
Table 61. Key Market Challenges & Risks of Obesity Treatment Devices
Table 62. Key Industry Trends of Obesity Treatment Devices
Table 63. Obesity Treatment Devices Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Obesity Treatment Devices Distributors List
Table 66. Obesity Treatment Devices Customer List
Table 67. Global Obesity Treatment Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Obesity Treatment Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Obesity Treatment Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Obesity Treatment Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Obesity Treatment Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Obesity Treatment Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Obesity Treatment Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Obesity Treatment Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Obesity Treatment Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Obesity Treatment Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Obesity Treatment Devices Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Obesity Treatment Devices Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Obesity Treatment Devices Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Obesity Treatment Devices Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Allergan, Inc. Basic Information, Obesity Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 82. Allergan, Inc. Obesity Treatment Devices Product Portfolios and Specifications
Table 83. Allergan, Inc. Obesity Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Allergan, Inc. Main Business
Table 85. Allergan, Inc. Latest Developments
Table 86. Apollo Endosurgery, Inc. Basic Information, Obesity Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 87. Apollo Endosurgery, Inc. Obesity Treatment Devices Product Portfolios and Specifications
Table 88. Apollo Endosurgery, Inc. Obesity Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Apollo Endosurgery, Inc. Main Business
Table 90. Apollo Endosurgery, Inc. Latest Developments
Table 91. Aspire Medical, Inc. (Aspire Bariatrics) Basic Information, Obesity Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 92. Aspire Medical, Inc. (Aspire Bariatrics) Obesity Treatment Devices Product Portfolios and Specifications
Table 93. Aspire Medical, Inc. (Aspire Bariatrics) Obesity Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Aspire Medical, Inc. (Aspire Bariatrics) Main Business
Table 95. Aspire Medical, Inc. (Aspire Bariatrics) Latest Developments
Table 96. Boston Scientific Corp. Basic Information, Obesity Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 97. Boston Scientific Corp. Obesity Treatment Devices Product Portfolios and Specifications
Table 98. Boston Scientific Corp. Obesity Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Boston Scientific Corp. Main Business
Table 100. Boston Scientific Corp. Latest Developments
Table 101. Cousin Biotech Basic Information, Obesity Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 102. Cousin Biotech Obesity Treatment Devices Product Portfolios and Specifications
Table 103. Cousin Biotech Obesity Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Cousin Biotech Main Business
Table 105. Cousin Biotech Latest Developments
Table 106. CR Bard, Inc. Basic Information, Obesity Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 107. CR Bard, Inc. Obesity Treatment Devices Product Portfolios and Specifications
Table 108. CR Bard, Inc. Obesity Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. CR Bard, Inc. Main Business
Table 110. CR Bard, Inc. Latest Developments
Table 111. EnteroMedics, Inc. Basic Information, Obesity Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 112. EnteroMedics, Inc. Obesity Treatment Devices Product Portfolios and Specifications
Table 113. EnteroMedics, Inc. Obesity Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. EnteroMedics, Inc. Main Business
Table 115. EnteroMedics, Inc. Latest Developments
Table 116. GI Dynamics, Inc. Basic Information, Obesity Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 117. GI Dynamics, Inc. Obesity Treatment Devices Product Portfolios and Specifications
Table 118. GI Dynamics, Inc. Obesity Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. GI Dynamics, Inc. Main Business
Table 120. GI Dynamics, Inc. Latest Developments
Table 121. GI Windows, Inc. Basic Information, Obesity Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 122. GI Windows, Inc. Obesity Treatment Devices Product Portfolios and Specifications
Table 123. GI Windows, Inc. Obesity Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. GI Windows, Inc. Main Business
Table 125. GI Windows, Inc. Latest Developments
Table 126. Johnson & Johnson Basic Information, Obesity Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 127. Johnson & Johnson Obesity Treatment Devices Product Portfolios and Specifications
Table 128. Johnson & Johnson Obesity Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Johnson & Johnson Main Business
Table 130. Johnson & Johnson Latest Developments
Table 131. Leptos Biomedical Basic Information, Obesity Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 132. Leptos Biomedical Obesity Treatment Devices Product Portfolios and Specifications
Table 133. Leptos Biomedical Obesity Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Leptos Biomedical Main Business
Table 135. Leptos Biomedical Latest Developments
Table 136. Mediflex Surgical Products Basic Information, Obesity Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 137. Mediflex Surgical Products Obesity Treatment Devices Product Portfolios and Specifications
Table 138. Mediflex Surgical Products Obesity Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. Mediflex Surgical Products Main Business
Table 140. Mediflex Surgical Products Latest Developments
Table 141. Medtronic, Inc. Basic Information, Obesity Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 142. Medtronic, Inc. Obesity Treatment Devices Product Portfolios and Specifications
Table 143. Medtronic, Inc. Obesity Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 144. Medtronic, Inc. Main Business
Table 145. Medtronic, Inc. Latest Developments
Table 146. ReShape Medical, Inc. Basic Information, Obesity Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 147. ReShape Medical, Inc. Obesity Treatment Devices Product Portfolios and Specifications
Table 148. ReShape Medical, Inc. Obesity Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 149. ReShape Medical, Inc. Main Business
Table 150. ReShape Medical, Inc. Latest Developments
Table 151. Satiety, Inc. Basic Information, Obesity Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 152. Satiety, Inc. Obesity Treatment Devices Product Portfolios and Specifications
Table 153. Satiety, Inc. Obesity Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 154. Satiety, Inc. Main Business
Table 155. Satiety, Inc. Latest Developments
Table 156. Spatz FGIA, Inc. Basic Information, Obesity Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 157. Spatz FGIA, Inc. Obesity Treatment Devices Product Portfolios and Specifications
Table 158. Spatz FGIA, Inc. Obesity Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 159. Spatz FGIA, Inc. Main Business
Table 160. Spatz FGIA, Inc. Latest Developments
Table 161. TransEnterix, Inc. Basic Information, Obesity Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 162. TransEnterix, Inc. Obesity Treatment Devices Product Portfolios and Specifications
Table 163. TransEnterix, Inc. Obesity Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 164. TransEnterix, Inc. Main Business
Table 165. TransEnterix, Inc. Latest Developments
List of Figures
Figure 1. Picture of Obesity Treatment Devices
Figure 2. Obesity Treatment Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Obesity Treatment Devices Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Obesity Treatment Devices Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Obesity Treatment Devices Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Gastric Banding Systems
Figure 10. Product Picture of Gastric Balloon Systems
Figure 11. Product Picture of Gastric Electrical Stimulation Systems
Figure 12. Product Picture of Gastric Emptying Systems or Gastric Aspiration Systems
Figure 13. Product Picture of Other
Figure 14. Global Obesity Treatment Devices Sales Market Share by Type in 2022
Figure 15. Global Obesity Treatment Devices Revenue Market Share by Type (2018-2023)
Figure 16. Obesity Treatment Devices Consumed in Hospitals
Figure 17. Global Obesity Treatment Devices Market: Hospitals (2018-2023) & (K Units)
Figure 18. Obesity Treatment Devices Consumed in Clinics
Figure 19. Global Obesity Treatment Devices Market: Clinics (2018-2023) & (K Units)
Figure 20. Obesity Treatment Devices Consumed in Others
Figure 21. Global Obesity Treatment Devices Market: Others (2018-2023) & (K Units)
Figure 22. Global Obesity Treatment Devices Sales Market Share by Application (2022)
Figure 23. Global Obesity Treatment Devices Revenue Market Share by Application in 2022
Figure 24. Obesity Treatment Devices Sales Market by Company in 2022 (K Units)
Figure 25. Global Obesity Treatment Devices Sales Market Share by Company in 2022
Figure 26. Obesity Treatment Devices Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Obesity Treatment Devices Revenue Market Share by Company in 2022
Figure 28. Global Obesity Treatment Devices Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Obesity Treatment Devices Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Obesity Treatment Devices Sales 2018-2023 (K Units)
Figure 31. Americas Obesity Treatment Devices Revenue 2018-2023 ($ Millions)
Figure 32. APAC Obesity Treatment Devices Sales 2018-2023 (K Units)
Figure 33. APAC Obesity Treatment Devices Revenue 2018-2023 ($ Millions)
Figure 34. Europe Obesity Treatment Devices Sales 2018-2023 (K Units)
Figure 35. Europe Obesity Treatment Devices Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Obesity Treatment Devices Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Obesity Treatment Devices Revenue 2018-2023 ($ Millions)
Figure 38. Americas Obesity Treatment Devices Sales Market Share by Country in 2022
Figure 39. Americas Obesity Treatment Devices Revenue Market Share by Country in 2022
Figure 40. Americas Obesity Treatment Devices Sales Market Share by Type (2018-2023)
Figure 41. Americas Obesity Treatment Devices Sales Market Share by Application (2018-2023)
Figure 42. United States Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Obesity Treatment Devices Sales Market Share by Region in 2022
Figure 47. APAC Obesity Treatment Devices Revenue Market Share by Regions in 2022
Figure 48. APAC Obesity Treatment Devices Sales Market Share by Type (2018-2023)
Figure 49. APAC Obesity Treatment Devices Sales Market Share by Application (2018-2023)
Figure 50. China Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Obesity Treatment Devices Sales Market Share by Country in 2022
Figure 58. Europe Obesity Treatment Devices Revenue Market Share by Country in 2022
Figure 59. Europe Obesity Treatment Devices Sales Market Share by Type (2018-2023)
Figure 60. Europe Obesity Treatment Devices Sales Market Share by Application (2018-2023)
Figure 61. Germany Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Obesity Treatment Devices Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Obesity Treatment Devices Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Obesity Treatment Devices Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Obesity Treatment Devices Sales Market Share by Application (2018-2023)
Figure 70. Egypt Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Obesity Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Obesity Treatment Devices in 2022
Figure 76. Manufacturing Process Analysis of Obesity Treatment Devices
Figure 77. Industry Chain Structure of Obesity Treatment Devices
Figure 78. Channels of Distribution
Figure 79. Global Obesity Treatment Devices Sales Market Forecast by Region (2024-2029)
Figure 80. Global Obesity Treatment Devices Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Obesity Treatment Devices Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Obesity Treatment Devices Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Obesity Treatment Devices Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Obesity Treatment Devices Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の肥満治療装置市場予測 2023年-2029年(Global Obesity Treatment Devices Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の分娩後異常出血（PPH）治療装置市場予測 2023年-2029年
  • 世界の分娩後異常出血（PPH）治療機器市場予測 2023年-2029年
  • 世界の移動式脳卒中治療ユニット市場予測 2023年-2029年
  • 世界の脊椎装置＆生物製剤市場予測 2023年-2029年
  • 世界の肝斑治療用レーザー市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆